HT
LXRX icon

HAP Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

HAP Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,800
Closed -$20K – 2192
2022
Q1 		$20K Buy
11,800
+1,800
+18% +$4.99K ﹤0.01% 1565
2021
Q4 		$8K Buy
+10,000
New +$48.6K ﹤0.01% 2112
2021
Q1 		– Sell
-17,000
Closed -$3K – 2172
2020
Q4 		$3K Buy
+17,000
New +$32.4K ﹤0.01% 2089
2020
Q2 		– Sell
-11,000
Closed -$31K – 1828
2020
Q1 		$31K Buy
+11,000
New +$32.7K ﹤0.01% 858
2019
Q1 		– Sell
-175,700
Closed -$588K – 1258
2018
Q4 		$588K Buy
175,700
+700
+0.4% +$5.67K 0.04% 338
2018
Q3 		$171K Buy
+175,000
New +$2.01M 0.01% 477
2017
Q4 		– Sell
-267,900
Closed -$489K – 1094
2017
Q3 		$489K Buy
+267,900
New +$3.96M 0.02% 362

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HAP Trading's LXRX Position: Q1 2019 in Review

HAP Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2019, closing a stake of 143,537 shares — an estimated $872K sold.

HAP Trading first reported a position in LXRX in Q3 2017 and held it in 3 quarters. The position peaked at $1.86M in Q3 2017. 121 funds tracked by Wall St. Rank hold LXRX as of Q1 2019.

  • HAP Trading reported no remaining Lexicon Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • HAP Trading sold 143,537 Lexicon Pharmaceuticals shares in Q1 2019, an estimated $872K.
  • HAP Trading first reported a position in Lexicon Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • HAP Trading's Lexicon Pharmaceuticals position peaked at $1.86M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2019.

Based on HAP Trading's 13F filing for Q1 2019, filed 10 May 2019.